Award Data

The purpose of this project is to develop a device that provides rapid intermittent compression to the residual limb of amputees that do not have good blood flow in their limbs. During Phase II, the project develops an actuator that: (1) mimics the pressures and rise times of currently available pneumatic intermittent compression systems, (2) produces a compression profile that has been shown to b ...

In previous Phase I research, this project demonstrated the technical merit, feasibility, and cost efficiency of combining commercially available technology with sophisticated pattern recognition and speech recognition and synthesis technology with an innovative approach and state-of-the-art software to deliver HomePortal, a universal console system to aid with daily living activities and remove b ...

DESCRIPTION provided by applicant Falls are the leading cause of fatal and nonfatal injuries among older adults andgt years and result in $ billion in annual medical costs Medical alert devices commonly worn as a pendant can be used to signal for help in the event of a fall More recently medical alert devices with automatic fall detection functionality have been developed These de ...

DESCRIPTION provided by applicant The goal of this Phase II is to enhance the availability of advanced brain and behavior research tools PA by developing an automated sensor based means of tracking the presence and severity of a broad spectrum of movement disorders during unscripted activities of daily living The continuously updated and interpreted information from body worn sensors ...

In this Phase II program we will build on the promising Phase I results and further develop, optimize and integrate self-healing coatings/membranes into Chemical/Biological (CB) protective clothing to enable autonomous and rapid self-healing of cuts/tears/punctures and provide continuous protection to the warfighters. Current CB garment systems use a layer of absorptive carbon or selectively perm ...

DESCRIPTION provided by applicant Tetragenetics Inc an early stage biotechnology company in Cambridge MA has developed a powerful cross cutting technology for the overexpression of eukaryotic membrane and secreted proteins using Tetrahymena thermophila an important model organism with a unique features particularly well suited to the production of these important classes of proteins The com ...

DESCRIPTION provided by applicant Pharmaco Photonics DBA FAST Biomedical proposes a PHASE IIB project to determine the safety and functionality of repeat administration of the FAST PV and mGFR Technology in both non clinical and clinical studies The long term goal of this SBIR project is to test FASTandapos s fluorescent based test in humans and commercializes this product for rapid detecti ...

Air management solutions capable of reducing heat and moisture burden are not suitable for integration in wearable respiratory protection systems due to excessive weight, volume, and power requirements of existing technologies. Vibrant Composites proposes applying its unique uMECS manufacturing technology towards development of an ultra-lightweight and power efficient miniature blower. Fundamental ...

DESCRIPTION provided by applicant Medical marijuana is now approved in states and the District of Columbia for several medical conditions such as cachexia cancer chronic pain epilepsy and other disorders characterized by seizures glaucoma HIV AIDS Multiple Sclerosis muscle spasticity and nausea Progress has been made on several fronts on the use of cannabinoids for medical use such ...

DESCRIPTION provided by applicant Physical Sciences Inc in collaboration with the University of Connecticut and SP Scientific will develop a combined hardware software product that will enable pharmaceutical scientists to rapidly develop robust product freeze drying cycles on both laboratory and production scale lyophilizers The product development will be accomplished through the combination ...